|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5252334A
(en)
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5697899A
(en)
|
1995-02-07 |
1997-12-16 |
Gensia |
Feedback controlled drug delivery system
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US5656016A
(en)
|
1996-03-18 |
1997-08-12 |
Abbott Laboratories |
Sonophoretic drug delivery system
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US5779708A
(en)
|
1996-08-15 |
1998-07-14 |
Cyberdent, Inc. |
Intraosseous drug delivery device and method
|
|
JP2001500015A
(ja)
|
1996-09-06 |
2001-01-09 |
トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Ｔ７ポリメラーゼを利用する組換えアデノ随伴ウイルスの誘導可能な製造方法
|
|
US6177403B1
(en)
|
1996-10-21 |
2001-01-23 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal
|
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6251677B1
(en)
|
1997-08-25 |
2001-06-26 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
|
US6346415B1
(en)
|
1997-10-21 |
2002-02-12 |
Targeted Genetics Corporation |
Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors
|
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
WO1999061601A2
(en)
|
1998-05-28 |
1999-12-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav5 vector and uses thereof
|
|
US20030110526A1
(en)
|
1998-08-25 |
2003-06-12 |
Robert H. Brown |
Dysferlin mutations
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
US6498244B1
(en)
|
1999-05-28 |
2002-12-24 |
Cell Genesys, Inc. |
Adeno-associated virus capsid immunologic determinants
|
|
US6544786B1
(en)
|
1999-10-15 |
2003-04-08 |
University Of Pittsburgh Of The Commonwealth Of Higher Education |
Method and vector for producing and transferring trans-spliced peptides
|
|
US7638120B2
(en)
|
2000-03-14 |
2009-12-29 |
Thomas Jefferson University |
High transgene expression of a pseudotyped adeno-associated virus type
|
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
|
US6962815B2
(en)
|
2001-01-05 |
2005-11-08 |
Children's Hopital Inc. |
AAV2 vectors and methods
|
|
WO2003004660A1
(en)
|
2001-07-03 |
2003-01-16 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods of administering vectors to synaptically connected neurons
|
|
ES2606290T3
(es)
*
|
2001-07-12 |
2017-03-23 |
University Of Massachusetts |
Producción in vivo de ARN de interferencia pequeños que median el silenciamiento génico
|
|
WO2003006616A2
(en)
|
2001-07-13 |
2003-01-23 |
University Of Iowa Research Foundation |
Pseudotyped adeno-associated viruses and uses thereof
|
|
AU2002326589B2
(en)
*
|
2001-08-07 |
2008-06-05 |
University Of Delaware |
Compositions and methods for the prevention and treatment of Huntington's disease
|
|
SG168422A1
(en)
|
2001-11-13 |
2011-02-28 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
ES2526341T3
(es)
|
2001-12-17 |
2015-01-09 |
The Trustees Of The University Of Pennsylvania |
Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
|
|
US20050137153A1
(en)
|
2002-02-20 |
2005-06-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA)
|
|
WO2003089612A2
(en)
|
2002-04-17 |
2003-10-30 |
University Of Florida Research Foundation, Inc. |
IMPROVED rAAV VECTORS
|
|
WO2003089011A1
(en)
|
2002-04-19 |
2003-10-30 |
University Of Florida |
rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES
|
|
EP1359217B1
(en)
|
2002-04-29 |
2006-12-13 |
The Trustees of The University of Pennsylvania |
Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
|
|
US20060093589A1
(en)
|
2004-02-19 |
2006-05-04 |
Warrington Kenneth H |
Vp2-modified raav vector compositions and uses therefor
|
|
US20080274989A1
(en)
|
2002-08-05 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
|
|
US20050255086A1
(en)
|
2002-08-05 |
2005-11-17 |
Davidson Beverly L |
Nucleic acid silencing of Huntington's Disease gene
|
|
US20050106731A1
(en)
*
|
2002-08-05 |
2005-05-19 |
Davidson Beverly L. |
siRNA-mediated gene silencing with viral vectors
|
|
WO2004067753A2
(en)
|
2003-01-28 |
2004-08-12 |
Cellectis |
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
|
|
US20040219528A1
(en)
|
2003-04-15 |
2004-11-04 |
Morris David W. |
Novel therapeutic targets in cancer
|
|
US7387896B2
(en)
|
2003-03-26 |
2008-06-17 |
The Regents Of The University Of Michigan |
MicroRNA vectors
|
|
US20060228800A1
(en)
|
2003-05-15 |
2006-10-12 |
Shi-Lung Lin |
Novel Transgenic Methods Using intronic RNA
|
|
AU2004248136B2
(en)
|
2003-06-02 |
2011-09-15 |
University Of Massachusetts |
Methods and compositions for controlling efficacy of RNA silencing
|
|
US8680063B2
(en)
*
|
2003-09-12 |
2014-03-25 |
University Of Massachusetts |
RNA interference for the treatment of gain-of-function disorders
|
|
EP3910063A1
(en)
|
2003-09-30 |
2021-11-17 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
KR101246862B1
(ko)
|
2004-03-05 |
2013-03-27 |
베니텍 리미티드 |
ＲＮＡｉ 제제의 동시 전달을 위한 다중 프로모터 발현카세트
|
|
WO2005096781A2
(en)
|
2004-04-06 |
2005-10-20 |
University Of Massachusetts |
Methods and compositions for treating gain-of-function disorders using rna interference
|
|
WO2005116224A2
(en)
|
2004-05-18 |
2005-12-08 |
Children's Memorial Hospital |
Tetracycline-regulated adeno-associated viral (aav) vectors for gene delivery to the nervous system
|
|
US7427396B2
(en)
|
2004-06-03 |
2008-09-23 |
Genzyme Corporation |
AAV vectors for gene delivery to the lung
|
|
CN101124328A
(zh)
|
2004-12-15 |
2008-02-13 |
北卡罗来纳查佩尔山大学 |
嵌合载体
|
|
ATE524546T1
(de)
|
2005-03-25 |
2011-09-15 |
Medtronic Inc |
Verwendung von anti-tnf oder anti-il1-rnai zur unterdrückung der wirkung entzündungsfördernder cytokine zur lokalen schmerzbehandlung
|
|
EP3409296A1
(en)
|
2005-04-07 |
2018-12-05 |
The Trustees of the University of Pennsylvania |
Method of increasing the function of an aav vector
|
|
WO2006119432A2
(en)
|
2005-04-29 |
2006-11-09 |
The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services |
Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
|
|
SI2002003T1
(sl)
|
2005-05-27 |
2016-05-31 |
Ospedale San Raffaele S.R.L. |
Genski vektor, ki vsebuje mi-RNA
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
DE602006019455D1
(de)
|
2005-08-29 |
2011-02-17 |
Regulus Therapeutics Inc |
Verfahren für mir-122a-modulation
|
|
CN103642900B
(zh)
|
2006-01-05 |
2016-04-13 |
俄亥俄州立大学研究基金会 |
用于诊断和治疗实体癌的基于微小rna的方法和组合物
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
JP5823663B2
(ja)
|
2006-03-03 |
2015-11-25 |
プロミス ニューロサイエンシズ インコーポレイテッド |
ミスフォールドｓｏｄ１媒介疾患を処置および検出するための方法および組成物
|
|
EP2007795B1
(en)
|
2006-03-30 |
2016-11-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid proteins
|
|
EP2046993A4
(en)
*
|
2006-07-07 |
2010-11-17 |
Univ Massachusetts |
RNA SILENCING COMPOSITIONS, AND METHODS OF TREATING HUNTINGTON CHOREA
|
|
US20080199961A1
(en)
*
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
|
DK2094086T3
(da)
|
2006-11-08 |
2013-11-25 |
Veritas Bio LLC |
Indgivelse in vivo af dobbeltstrenget rna til en målcelle
|
|
EP3492596A1
(en)
|
2007-04-09 |
2019-06-05 |
University of Florida Research Foundation, Inc. |
Raav vector compositions having tyrosine-modified capsid proteins and methods for use
|
|
ES2907452T3
(es)
|
2007-04-12 |
2022-04-25 |
The Provost Fellows Found Scholars & The Other Members Of Board Of The College Of The Holy & Undiv T |
Supresión y reemplazo genético
|
|
JP2010525826A
(ja)
|
2007-05-03 |
2010-07-29 |
ロゼッタ インファーマティックス エルエルシー |
癌を治療するためのｍｉｒ３４治療剤を含む組成物
|
|
WO2008147837A1
(en)
|
2007-05-23 |
2008-12-04 |
Dharmacon, Inc. |
Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
|
|
ES2549122T3
(es)
|
2007-05-31 |
2015-10-23 |
University Of Iowa Research Foundation |
Reducción de toxicidad por interferencia de ARN desviada de su diana
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
US9090894B2
(en)
|
2007-12-17 |
2015-07-28 |
California Institute Of Technology |
Modulating immune system development and function through microRNA MIR-146
|
|
WO2009108274A2
(en)
|
2008-02-26 |
2009-09-03 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for adeno-associated virus (aav) with hi loop mutations
|
|
US8404659B2
(en)
|
2008-03-07 |
2013-03-26 |
Santaris Pharma A/S |
Pharmaceutical compositions for treatment of MicroRNA related diseases
|
|
WO2009146178A1
(en)
|
2008-04-15 |
2009-12-03 |
President And Fellows Of Harvard College |
Angiogenin and amyotrophic lateral sclerosis
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
EP2297322A1
(en)
|
2008-06-04 |
2011-03-23 |
The Board of Regents of The University of Texas System |
Modulation of gene expression through endogenous small rna targeting of gene promoters
|
|
US20110171262A1
(en)
|
2008-06-17 |
2011-07-14 |
Andrew Christian Bakker |
Parvoviral capsid with incorporated gly-ala repeat region
|
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
|
US20120053084A1
(en)
|
2008-09-04 |
2012-03-01 |
Galenea Corp. |
Synaptic vesicle cycling assays and systems
|
|
WO2010034314A1
(en)
|
2008-09-24 |
2010-04-01 |
Aarhus Universitet |
Retroviral delivery of synthectic gene cassettes
|
|
WO2010071454A1
(en)
|
2008-12-17 |
2010-06-24 |
Auckland Uniservices Limited |
Adeno-associated viral vectors and uses thereof
|
|
US20110305772A1
(en)
|
2009-02-26 |
2011-12-15 |
The Johns Hopkins University |
Compositions and methods for ex vivo hepatic nucleic acid delivery
|
|
AU2010243276B2
(en)
*
|
2009-04-30 |
2016-09-15 |
Fondazione Telethon Ets |
Gene vector
|
|
EP3988660B1
(en)
|
2009-05-02 |
2025-05-14 |
Genzyme Corporation |
Gene therapy for neurodegenerative disorders
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
EP2261242A1
(en)
|
2009-06-10 |
2010-12-15 |
Universite Catholique De Louvain |
Aspartate-N-acetyltransferase enzyme, diagnostic method and therapeutic method
|
|
EP3626823A1
(en)
*
|
2009-09-11 |
2020-03-25 |
Ionis Pharmaceuticals, Inc. |
Modulation of huntingtin expression
|
|
US20120270930A1
(en)
|
2009-10-29 |
2012-10-25 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Methods and compositions for dysferlin exon-skipping
|
|
US20120309816A1
(en)
|
2009-11-09 |
2012-12-06 |
Genepod Therapeutics Ab |
Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo
|
|
CN102741405B
(zh)
|
2009-11-19 |
2015-03-04 |
国立大学法人冈山大学 |
提高基因表达的系统和保持有该系统的载体
|
|
ES2683695T3
(es)
|
2010-01-12 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Repeticiones terminales invertidas restrictivas para vectores virales
|
|
WO2011094198A1
(en)
|
2010-01-28 |
2011-08-04 |
The Children's Hospital Of Philadelphia Research Institute, Abramson Research Center |
A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
|
|
WO2011109380A1
(en)
|
2010-03-01 |
2011-09-09 |
The Children's Hospital Of Philadelphia |
Nucleic acids for targeting multiple regions of the hcv genome
|
|
EP3540055A1
(en)
|
2010-04-23 |
2019-09-18 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
US9272053B2
(en)
|
2010-04-23 |
2016-03-01 |
University Of Massachusetts |
AAV-based treatment of cholesterol-related disorders
|
|
US8785413B2
(en)
|
2010-09-27 |
2014-07-22 |
Florida Atlantic University Research Corporation |
Materials and methods for the treatment of pathological neovascularization in the eye
|
|
EP2673286B1
(en)
|
2011-02-12 |
2019-07-03 |
University of Iowa Research Foundation |
Therapeutic compounds
|
|
SG10202007803QA
(en)
|
2011-02-17 |
2020-09-29 |
Univ Pennsylvania |
Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
WO2012142434A2
(en)
|
2011-04-15 |
2012-10-18 |
THE UNITED STATES OF AMERICA, as represented by the secretary, Depart.of Healtth and Human Services |
Aav mediated ctla-4 gene transfer to treat sjogren's syndrome
|
|
US9226976B2
(en)
|
2011-04-21 |
2016-01-05 |
University Of Massachusetts |
RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
US8609088B2
(en)
|
2011-05-10 |
2013-12-17 |
Regents Of The University Of Minnesota |
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
|
|
CN104011210B
(zh)
|
2011-10-11 |
2018-05-01 |
布里格姆及妇女医院股份有限公司 |
神经退行性病症中的microRNA
|
|
US20130142861A1
(en)
|
2011-12-05 |
2013-06-06 |
National Yang Ming University |
Compositions And Method For Detecting And Treating Abnormal Liver Homeostasis And Hepatocarcinogenesis
|
|
CN104520428B
(zh)
|
2012-02-17 |
2018-09-21 |
费城儿童医院 |
将基因转移到细胞、器官和组织的aav载体组合物和方法
|
|
JP6385920B2
(ja)
|
2012-05-09 |
2018-09-05 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
アデノ随伴ウイルスプラスミド及びベクター
|
|
US20150182637A1
(en)
|
2012-06-21 |
2015-07-02 |
Association Institut De Myologie |
Widespread gene delivery of gene therapy vectors
|
|
US20140066595A1
(en)
*
|
2012-09-04 |
2014-03-06 |
Thermo Fisher Scientific Biosciences Inc. |
Modulators of Protein Production in a Human Cell Line and Cell-free Extracts Produced Therefrom
|
|
BR112015013784A2
(pt)
|
2012-12-12 |
2017-07-11 |
Massachusetts Inst Technology |
aplicação, manipulação e otimização de sistemas, métodos e composições para manipulação de sequência e aplicações terapêuticas
|
|
NZ629569A
(en)
|
2013-01-14 |
2018-07-27 |
Recombinetics Inc |
Hornless livestock
|
|
CA2905952A1
(en)
|
2013-03-13 |
2014-10-02 |
The Children's Hospital Of Philadelphia |
Adeno-associated virus vectors and methods of use thereof
|
|
IL293294B2
(en)
|
2013-03-15 |
2023-04-01 |
Univ North Carolina Chapel Hill |
Methods and compounds for ligation of paired aav glycan vectors
|
|
EP2986635B1
(en)
|
2013-04-18 |
2018-10-03 |
Fondazione Telethon |
Effective delivery of large genes by dual aav vectors
|
|
US10006049B2
(en)
|
2013-05-16 |
2018-06-26 |
University Of Florida Research Foundation, Incorporated |
Hairpin mRNA elements and methods for the regulation of protein translation
|
|
KR20230136697A
(ko)
|
2013-06-05 |
2023-09-26 |
듀크 유니버시티 |
Rna-가이드 유전자 편집 및 유전자 조절
|
|
DK3011031T3
(da)
|
2013-06-17 |
2020-12-21 |
Broad Inst Inc |
Fremføring og anvendelse af crispr-cas-systemerne, vektorer og sammensætninger til levermålretning og -terapi
|
|
WO2015009575A1
(en)
|
2013-07-16 |
2015-01-22 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of disorders related to cep290
|
|
AU2014305218B2
(en)
|
2013-08-05 |
2020-01-16 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
Recombinant AAV-Crumbs homologue composition and methods for treating LCA-8 and progressive RP
|
|
HRP20200862T1
(hr)
|
2013-08-27 |
2020-08-21 |
Research Institute At Nationwide Children's Hospital |
Proizvodi i metode liječenja amiotrofične lateralne skleroze
|
|
EP3068905A4
(en)
*
|
2013-11-11 |
2017-07-05 |
Sangamo BioSciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
GB201401707D0
(en)
|
2014-01-31 |
2014-03-19 |
Sec Dep For Health The |
Adeno-associated viral vectors
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
HUE054748T2
(hu)
|
2014-03-17 |
2021-09-28 |
Hospital For Sick Children |
Béta-hexózaminidáz fehérje változatai és kapcsolódó eljárások GM2 gangliozidózis kezelésére
|
|
JP6756700B2
(ja)
|
2014-03-18 |
2020-09-16 |
ユニバーシティ オブ マサチューセッツ |
筋萎縮性側索硬化症を処置するためのｒＡＡＶベースの組成物および方法
|
|
EP3134522B1
(en)
|
2014-04-25 |
2021-10-06 |
University of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
LT3137497T
(lt)
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
|
RU2711147C2
(ru)
|
2014-05-20 |
2020-01-15 |
Юниверсити Оф Айова Рисерч Фаундейшн |
Терапевтические соединения для лечения болезни хантингтона
|
|
RU2738421C2
(ru)
|
2014-10-21 |
2020-12-14 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
|
EA037696B1
(ru)
|
2014-12-24 |
2021-05-12 |
ЮНИКЕР АйПи Б.В. |
Супрессия гена гентингтина, индуцированная рнк-интерференцией
|
|
PL3277814T3
(pl)
*
|
2015-04-03 |
2020-11-30 |
University Of Massachusetts |
Związki oligonukleotydowe ukierunkowane na mrna huntingtyny
|
|
WO2017023724A1
(en)
|
2015-07-31 |
2017-02-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|